IBIO, INC. Notes Payable, Current
IBIO, INC. (IBIO) had Notes Payable, Current of $706.00 thousand as of 2025-09-30, per its 10-Q/A filed 2025-11-17.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities
us-gaap:NotesPayableCurrent · last filed 2026-08-28
- 2025-09-30: Notes Payable, Current $706.00K.
- 2025-06-30: Notes Payable, Current $766.00K.
- 2025-03-31: Notes Payable, Current $824.00K.
- 2024-12-31: Notes Payable, Current $237.00K.
| Period end | Notes Payable, Current |
|---|---|
| 2025-09-30 | $706.00K 10-Q/A · filed 2025-11-17 |
| 2025-06-30 | $766.00K 10-K · filed 2026-08-28 |
| 2025-03-31 | $824.00K 10-Q · filed 2025-05-02 |
| 2024-12-31 | $237.00K 10-Q · filed 2025-02-10 |
| 2024-09-30 | $227.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $218.00K 10-K · filed 2025-09-05 |
| 2024-03-31 | $12.65M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $12.65M 10-Q · filed 2024-02-09 |
| 2023-09-30 | $12.63M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $12.94M 10-Q · filed 2024-05-13 |
| 2023-03-31 | $13.70M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $16.01M 10-Q/A · filed 2023-05-19 |
| 2022-09-30 | $22.20M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $22.16M 10-K · filed 2023-09-27 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 |
| 2021-12-31 | $0.00 10-Q · filed 2022-02-14 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 |
| 2021-06-30 | $600.00K 10-K · filed 2022-10-11 |
| 2021-03-31 | $566.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $465.00K 10-Q · filed 2021-02-16 |
| 2020-09-30 | $362.00K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $261.00K 10-K · filed 2021-09-28 |
| 2020-03-31 | $1.20M 10-Q · filed 2020-05-15 |
| 2019-06-30 | $0.00 10-K · filed 2020-10-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |